The agreement was signed on January 15, 2018, in Moscow by Artur Parfenchikov, the Head of the Republic of Karelia, and Sudhanshu Tyagi, the managing director
of a German limited liability company B. Braun Avitum Russland.
The agreement of intent for investment into building a dialysis center in Karelia was signed by B. Braun Avitum Russland and Artur Parfenchikov, on behalf of Karelian government.
This investment project is aimed at improving quality and availability of medical care for patients with kidney failure who need renal replacement therapy.
"We are looking forward to building a world-class hemodialysis center in Karelia, because it will serve the best interests of local people," Artur Parfenchikov said.
Parfenchikov described Karelia as an attractive region for healthcare investments and expressed his interest in extensive cooperation with B. Braun Avitum Russland.
The Company's managing director Sudhanshu Tyagi, in turn, assured the Karelian side that they are ready to commence as soon as possible.
"I'm sure that the project will be completed promptly and in compliance with the highest standards," Sudhanshu Tyagi said.
B. Braun is a German medical and pharmaceutical device company with offices in more than 60 countries, which has been successfully doing business in Russia for many years.
Its subsidiary company B. Braun Avitum Russland is delivering hemodialysis equipment and supplies for treating patients with chronic kidney disease (CKD).
Hemodialysis is a process of using artificial kidney for removing toxins, waste products, and extra fluid from the bloodstream of a patient with CKD whose kidneys are
not functioning properly. Hemodialysis, peritoneal dialysis and renal transplantation are the only ways to extend life expectancy for CKD patients.
B. Braun invests in building its own dialysis centers in many countries of the world, including Russia.
B. Braun Avitum Russland currently owns and manages 52 dialysis centers, which provide healthcare services to approximately 6,000 patients.